Innoviva, Inc. - stock earnings
INVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 61.5 million USD | 89.3 million USD |
| 2023Q3 | 82.0 million USD | 67.3 million USD |
| 2023Q2 | 1.3 million USD | 81.0 million USD |
| 2023Q1 | 34.9 million USD | 76.4 million USD |
| 2022Q4 | -68.3 million USD | 65.8 million USD |
| 2022Q3 | 265.5 million USD | 67.3 million USD |
| 2022Q2 | 939000 USD | 108.2 million USD |
| 2022Q1 | 15.8 million USD | 90.1 million USD |
| 2021Q4 | 10.3 million USD | 107.7 million USD |
| 2021Q3 | 72.4 million USD | 97.9 million USD |
| 2021Q2 | 88.9 million USD | 100.8 million USD |
| 2021Q1 | 94.1 million USD | 85.5 million USD |
| 2020Q4 | 53.9 million USD | 90.5 million USD |
| 2020Q3 | 28.2 million USD | 88.7 million USD |
| 2020Q2 | 76.8 million USD | 78.9 million USD |
| 2020Q1 | 65.4 million USD | 78.7 million USD |
| 2019Q4 | 45.9 million USD | 76.0 million USD |
| 2019Q3 | 39.8 million USD | 65.8 million USD |
| 2019Q2 | 37.7 million USD | 64.1 million USD |
| 2019Q1 | 33.8 million USD | 55.2 million USD |
| 2018Q4 | 263.8 million USD | 79.9 million USD |
| 2018Q3 | 47.1 million USD | 61.7 million USD |
| 2018Q2 | 54.6 million USD | 67.1 million USD |
| 2018Q1 | 29.6 million USD | 52.4 million USD |
| 2017Q4 | 58.4 million USD | 69.5 million USD |
| 2017Q3 | 23.8 million USD | 48.6 million USD |
| 2017Q2 | 35.1 million USD | 58.6 million USD |
| 2017Q1 | 16.8 million USD | 40.5 million USD |
| 2016Q4 | 25.5 million USD | 43.6 million USD |
| 2016Q3 | 15.0 million USD | 33.3 million USD |
| 2016Q2 | 14.6 million USD | 32.5 million USD |
| 2016Q1 | 4.4 million USD | 24.2 million USD |
| 2015Q4 | 4.3 million USD | 22.8 million USD |
| 2015Q3 | -4.6 million USD | 13.6 million USD |
| 2015Q2 | -7.8 million USD | 10.7 million USD |
| 2015Q1 | -10.7 million USD | 6.9 million USD |
| 2014Q4 | -15.9 million USD | 7.3 million USD |
| 2014Q3 | -21.3 million USD | 999000 USD |
| 2014Q2 | -63.6 million USD | 934000 USD |
| 2014Q1 | -67.7 million USD | 165000 USD |
| 2013Q4 | -49.9 million USD | 1.6 million USD |
| 2013Q3 | -47.0 million USD | 439000 USD |
| 2013Q2 | -36.4 million USD | 1.3 million USD |
| 2013Q1 | -37.4 million USD | 1.3 million USD |
| 2012Q4 | -31.3 million USD | 5.8 million USD |
| 2012Q3 | -34.7 million USD | 1.4 million USD |
| 2012Q2 | -37.1 million USD | 1.4 million USD |
| 2012Q1 | 84.6 million USD | 127.1 million USD |
| 2011Q4 | -37.0 million USD | 5.4 million USD |
| 2011Q3 | -30.6 million USD | 6.4 million USD |
| 2011Q2 | -25.0 million USD | 6.4 million USD |
| 2011Q1 | -22.7 million USD | 6.3 million USD |
| 2010Q4 | -19.3 million USD | 6.9 million USD |
| 2010Q3 | -21.2 million USD | 5.3 million USD |
| 2010Q2 | -20.8 million USD | 6.3 million USD |
| 2010Q1 | -22.5 million USD | 5.7 million USD |
| 2009Q4 | -22.2 million USD | 3.8 million USD |
| 2009Q3 | -22.2 million USD | 5.5 million USD |
| 2009Q2 | -21.7 million USD | 5.5 million USD |
| 2009Q1 | -19.2 million USD | 9.5 million USD |
| 2008Q4 | -15.9 million USD | 5.9 million USD |
| 2008Q3 | -20.9 million USD | 6.0 million USD |
| 2008Q2 | -27.0 million USD | 5.5 million USD |
| 2008Q1 | -29.8 million USD | 5.6 million USD |
| 2007Q4 | -33.1 million USD | 5.6 million USD |
| 2007Q3 | -32.4 million USD | 5.7 million USD |
| 2007Q2 | -45.1 million USD | 5.3 million USD |
| 2007Q1 | -49.5 million USD | 5.4 million USD |
| 2006Q4 | -37.8 million USD | 4.9 million USD |
| 2006Q3 | -37.8 million USD | 5.5 million USD |
| 2006Q2 | -41.5 million USD | 4.8 million USD |
| 2006Q1 | -49.0 million USD | 4.3 million USD |
| 2005Q4 | -42.2 million USD | 3.4 million USD |
| 2005Q3 | -37.8 million USD | 3.0 million USD |
| 2005Q2 | -31.7 million USD | 2.9 million USD |
| 2005Q1 | -31.5 million USD | 2.8 million USD |
| 2004Q4 | -29.2 million USD | 2.7 million USD |
| 2004Q3 | -22.3 million USD | 2.6 million USD |
| 2004Q2 | -25.6 million USD | 1.8 million USD |
| 2004Q1 | ? USD | 1.4 million USD |
| 2003Q4 | ? USD | 1.3 million USD |
| 2003Q3 | ? USD | 997000 USD |
| 2003Q2 | ? USD | 1.3 million USD |
| 2002Q4 | ? USD | 156000 USD |
INVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 179.7 million USD | 324.3 million USD |
| 2022 | 213.9 million USD | 331.3 million USD |
| 2021 | 265.9 million USD | 391.9 million USD |
| 2020 | 224.4 million USD | 336.8 million USD |
| 2019 | 157.3 million USD | 261.0 million USD |
| 2018 | 395.1 million USD | 261.0 million USD |
| 2017 | 134.1 million USD | 217.2 million USD |
| 2016 | 59.5 million USD | 133.6 million USD |
| 2015 | -18.8 million USD | 53.9 million USD |
| 2014 | -168.5 million USD | 8.4 million USD |
| 2013 | -170.7 million USD | 4.8 million USD |
| 2012 | -18.5 million USD | 135.8 million USD |
| 2011 | -115.3 million USD | 24.5 million USD |
| 2010 | -83.9 million USD | 24.2 million USD |
| 2009 | -85.3 million USD | 24.4 million USD |
| 2008 | -93.6 million USD | 23.1 million USD |
| 2007 | -160.0 million USD | 22.0 million USD |
| 2006 | -166.0 million USD | 19.6 million USD |
| 2005 | -143.2 million USD | 12.1 million USD |
| 2004 | -102.7 million USD | 8.9 million USD |
| 2003 | -70.6 million USD | 3.6 million USD |
| 2002 | -79.2 million USD | 156000 USD |
| 2001 | -64.8 million USD | ? USD |
| 2000 | -94.9 million USD | ? USD |
INVA
Price: $15.26
52 week price:
Earnings Per Share: 2.20 USD
P/E Ratio: 20.80
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 549332
Ebitda: 66.9 millionMarket Capitalization: 925.0 million
Average Dividend Frequency: 3